Acyclovir

CHEMBL184 Phase 4 Đã phê duyệt Small molecule
Half-Life
2.5-3.3 hours
Bioavailability
Protein Binding
Molecular Weight
225.2 g/mol
LogP
-1.9
Phase
4

An antiviral medication that stops the herpes simplex and varicella-zoster viruses from replicating by mimicking one of the building blocks the virus needs to copy its DNA. It is used to treat cold sores, genital herpes, chickenpox, and shingles, and can reduce the severity and duration of outbreaks when started early. Long-term daily use at a lower dose can suppress recurrent outbreaks in people with frequent episodes.

Khối lượng phân tử

225,2050 g/mol

LogP

-1,90

TPSA

115,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Phân loại thuốc

Cơ chế tác dụng

Guanosine analogue inhibiting viral DNA polymerase.

Pharmacokinetics (PK)

Half-Life 2.5-3.3 hours

Pharmacodynamics (PD)

Cơ chế

Guanosine analogue inhibiting viral DNA polymerase.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1nc2c(ncn2COCCO)c(=O)[nH]1

InChI

InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)

Molecular Formula

C8H11N5O3

HBD / HBA

3 / 5

Liên kết có thể quay

4

Nguyên tử nặng

16

Primary Target

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

An antiviral medication that stops the herpes simplex and varicella-zoster viruses from replicating by mimicking one of the building blocks the virus needs to copy its DNA. It is used to treat cold sores, genital herpes, chickenpox, and shingles, and can reduce the severity and duration of outbreaks when started early. Long-term daily use at a lower dose can suppress recurrent outbreaks in people with frequent episodes.

Guanosine analogue inhibiting viral DNA polymerase.

Key pharmacokinetic parameters for Acyclovir: Half-life: 2.5-3.3 hours.

Yes, Acyclovir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL184. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135398513. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.